TranS1 Inc. (TSON) Set Nearly A 6-Month High After AMA Approval

(RTTNews.com) – TranS1 Inc. (TSON) announced Monday morning that the American Medical Association Current Procedural Terminology Panel has voted to approve an application for a Category I CPT code for L5-S1 spinal fusion, utilizing TranS1’s pre-sacral interbody fusion approach with its AxiaLIF implant.

TranS1 gapped up sharply Monday, but traded in a range for the majority of the session. The stock closed up by 0.79 at $4.07, with volume at over an 11-month high. TranS1 jumped to nearly a 6-month high.

For comments and feedback: contact editorial@rttnews.com



Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Themed By Curio Display Cabinets